In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

A panelist discusses how comprehensive molecular testing at MBC diagnosis, including genomic profiling and ESR1 mutation status, helps guide treatment decisions and identify potential therapeutic ...

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the expanded commercial availability of the NavDx test for Molecular Residual Disease (MRD) ...

Like many cancer patients, Michael Wolff wanted answers. But, like many cancer patients in 2015, he wasn't getting them.

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

Breakthroughs in laboratory and data science are increasing interest in blood tests to screen for cancer, with colorectal ...

Exact Sciences' 2024 sales grew 10% to $2.76 billion, exceeding estimates. New cancer tests, including Cologuard Plus, are ...

If you are one of the millions of women identified as having dense breasts, your health care team may recommend supplemental or additional screening to check your breasts for cancer.

In the era of precision oncology, research focused on evaluating molecular profiles and optimizing molecular testing in advanced NSCLC is increasingly crucial, particularly in low- and middle-income ...

an important milestone toward making the test available for ... A Battle of Rafts: How Molecular Dynamics in CAR T Cells Explain Their Cancer-Killing Behavior Jan. 10, 2025 — A study shares new ...